Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Oct 24, 2024
Date Accepted: Jan 21, 2025

The final, peer-reviewed published version of this preprint can be found here:

Cutaneous Atrophy Following Corticosteroid Injections for Tendonitis: Report of Two Cases

Colwell R, Gullickson M, Cutlan J, Stratman E

Cutaneous Atrophy Following Corticosteroid Injections for Tendonitis: Report of Two Cases

JMIR Dermatol 2025;8:e67921

DOI: 10.2196/67921

PMID: 39946745

PMCID: 11841998

Cutaneous atrophy following corticosteroid injection for tendonitis: A report of two cases

  • Rebecca Colwell; 
  • Mitchell Gullickson; 
  • Jonathan Cutlan; 
  • Erik Stratman

ABSTRACT

Cutaneous atrophy resulting from corticosteroid injections for musculoskeletal indications is an underrecognized side effect amongst orthopedists and dermatologists. We present two cases of cutaneous atrophy following corticosteroid injections for tendonitis of the wrist. Patients presenting with cutaneous atrophy following orthopedic corticosteroid injections may be misdiagnosed with linear morphea, atrophoderma, or vascular disorders and receive unnecessary workup and delays in appropriate management. Dermatologists play an essential role in the evaluation of these patients.


 Citation

Please cite as:

Colwell R, Gullickson M, Cutlan J, Stratman E

Cutaneous Atrophy Following Corticosteroid Injections for Tendonitis: Report of Two Cases

JMIR Dermatol 2025;8:e67921

DOI: 10.2196/67921

PMID: 39946745

PMCID: 11841998

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.